Robin Guo
Impact in
- Hepatology top 5%
- Liver physiology and pathology
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 15
- Peptidase Inhibition and Analysis 4
- Lung Cancer Research Studies 3
- Cancer-related Molecular Pathways 3
-
- Lung Cancer Treatments and Mutations 10
- Occupational and environmental lung diseases 2
- Co-authors
- Alexander Drilon (10 shared papers)Natasha Rekhtman (5 shared papers)Jason C. Chang (4 shared papers)Maria E. Arcila (4 shared papers)Jia Luo (2 shared papers)Mark G. Kris (9 shared papers)Lufen Chang (3 shared papers)Yun Yen (3 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Journal of Thoracic Oncology (5 papers)Annals of Oncology (3 papers)JCO Precision Oncology (2 papers)Nature Reviews Clinical Oncology (1 paper)
- Partner nations
- United StatesTaiwanSpain
In The Last Decade
Robin Guo
25 papers receiving 605 citations
Peers
Comparison fields: 5 of 64
- Hepatology 126
- Pulmonary and Respiratory Medicine 306
- Oncology 234
- Cancer Research 109
- Pathology and Forensic Medicine 74
Countries citing papers authored by Robin Guo
This map shows the geographic impact of Robin Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Guo more than expected).
Fields of papers citing papers by Robin Guo
This network shows the impact of papers produced by Robin Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Guo. The network helps show where Robin Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 210 | |
| 2 | 2019 | 116 | |
| 3 | 2008 | 56 | |
| 4 | 2019 | 33 | |
| 5 | 2013 | 23 | |
| 6 | 2019 | 22 | |
| 7 | 2019 | 22 | |
| 8 | 2019 | 21 | |
| 9 | 2020 | 18 | |
| 10 | 2021 | 17 | |
| 11 | 2017 | 15 | |
| 12 | 2022 | 14 | |
| 13 | 2024 | 7 | |
| 14 | 2011 | 7 | |
| 15 | 2021 | 6 | |
| 16 | 2024 | 5 | |
| 17 | 2020 | 4 | |
| 18 | 2019 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2023 | 2 |
About Robin Guo
Robin Guo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Surgery, having authored 27 papers that have together received 611 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Chromatin Remodeling and Cancer (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Peptidase Inhibition and Analysis (4 papers), Mechanisms of cancer metastasis (3 papers), Lung Cancer Research Studies (3 papers), Cancer-related Molecular Pathways (3 papers) and Occupational and environmental lung diseases (2 papers). The work is most often cited by research in Hepatology (126 citations), Pulmonary and Respiratory Medicine (306 citations), Oncology (234 citations), Cancer Research (109 citations) and Pathology and Forensic Medicine (74 citations). Robin Guo has collaborated with scholars based in United States, Taiwan and Spain. Frequent co-authors include Alexander Drilon, Natasha Rekhtman, Jason C. Chang, Maria E. Arcila, Jia Luo, Mark G. Kris, Lufen Chang, Yun Yen, Jamie Sheren and David J. Kwiatkowski. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, JCO Precision Oncology and Nature Reviews Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.